脑动静脉畸形栓塞作为辅助治疗的风险因素:单中心10年经验
该单中心回顾性研究纳入2011年4月至2021年5月接受栓塞治疗的脑动静脉畸形(AVM)患者,共36例AVM、58次栓塞。每次栓塞并发症率为43%(25/58),每例患者为36%(13/36);n-BCA栓塞是术后出血的显著风险因素(单因素79% vs 36%,P=0.012;多因素OR 4.90,95%CI 1.08-22.2,P=0.039)。
要点
- 每次栓塞并发症率43%(25/58),每例患者并发症率36%(13/36)。
- 缺血性和出血性并发症各14例(24%)。
- n-BCA栓塞与术后出血风险升高相关(OR 4.90,95%CI 1.08-22.2)。
核心结论
- 复杂脑AVM多模态治疗中栓塞的风险较高。
- n-BCA栓塞可能带来更高的术后出血风险。
- 未来需积累病例以研究最小靶向栓塞的有效性。
研究设计与样本
- 回顾性评估2011年4月至2021年5月在本院接受栓塞治疗的脑AVM患者。
- 共治疗36例AVM,实施58次栓塞。
- 分析围手术期和术后并发症的风险因素。
主要发现
- 栓塞目的:术前24例(67%),放射外科术前9例(25%),姑息性3例(8%)。
- 每次栓塞总体并发症率43%(25/58),每例患者36%(13/36)。
- 缺血性和出血性并发症各14例(24%)。
- n-BCA栓塞是术后出血的显著风险因素:单因素分析79% vs 36%(P=0.012,Fisher精确检验);多因素分析OR 4.90,95%CI 1.08-22.2,P=0.039。
- 单次栓塞供血动脉数量在出血并发症组有偏高的趋势(中位数3.5 vs 2.0,P=0.11,Mann-Whitney U检验)。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: In the multimodality treatment of complex brain arteriovenous malformations (AVMs), the role of endovascular embolization is not fully elucidated. To assess the risk of embolization, we retrospectively evaluated the outcomes of endovascular treatment for AVM, focusing on the embolization-related complications. METHODS: The present study included patients with brain AVM who underwent embolization at our hospital between April 2011 and May 2021. Risk factors for peri- and postoperative complications were analyzed. RESULTS: During the study period, 36 AVMs were treated during 58 embolization sessions. The goal of the embolization was preoperative in 24 (67%), pre-radiosurgical in 9 (25%), and palliative in 3 (8%) cases. The overall complication rate was 43% (25 of 58) per session and 36% (13 of 36) per patient. Ischemic and hemorrhagic complications were observed in 14 (24%) and 14 (24%) cases, respectively. n-Butyl cyanoacrylate (n-BCA) embolization was detected as the significant risk for postoperative hemorrhage in the univariate (79% vs. 36%, P = 0.012; Fisher exact test) and the multivariable analysis (odds ratio 4.90, 95% confidence interval 1.08-22.2, P = 0.039). The number of embolized feeder in a single session also tended to be higher in a hemorrhagic complication group (median 3.5 vs. 2.0, P = 0.11; Mann-Whitney U-test). CONCLUSIONS: The risk of embolization in multimodality treatment for complex brain AVM was substantial. n-BCA embolization may carry a higher risk of postoperative hemorrhage. An accumulation of cases is awaited to investigate the effectiveness of minimal target embolization in the future.
引用
- Koizumi S, Shojima M, Shinya Y, et al. Risk Factors of Brain Arteriovenous Malformation Embolization as Adjunctive Therapy: Single-Center 10-Year Experience. World Neurosurg. 2022. PMID: 36130658. doi:10.1016/j.wneu.2022.09.069
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。